GGrantIndex
← Leaderboards

Rhonda R Voskuhl

University Of California Los Angeles

$15,953,694
Attributed
$15,953,694
Total exposure
14
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.9M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,953,694 · 14

By mechanism

R01$11,693,075 · 6
R35$2,697,814 · 1
R21$802,231 · 2
K24$722,467 · 1
P41$38,107 · 4

Top collaborators

No co-investigators on record.

Most similar at University Of California Los Angeles

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsMultiple SclerosisDisabilityExperimental Autoimmune EncephalomyelitisGonadal Steroid HormonesTranslatingImmuneNerve DegenerationFemaleRelapseSex ChromosomesEstriolNeurologicBrainImmune ResponseCopaxoneCytokineGenesMaleMagnetic Resonance ImagingRelapsing-Remitting Multiple SclerosisBaseBackGene Expression

Grant awards (46)

Neurodegeneration Underlying Distinct Disabilities in Multiple Sclerosis Using a Cell-Specific, Region-Specific, and Sex-Specific Approach$922,109
R35 · FY2025 · NS · contact PI
Neurodegeneration Underlying Distinct Disabilities in Multiple Sclerosis Using a Cell-Specific, Region-Specific, and Sex-Specific Approach$894,212
R35 · FY2024 · NS · contact PI
Neurodegeneration Underlying Distinct Disabilities in Multiple Sclerosis Using a Cell-Specific, Region-Specific, and Sex-Specific Approach$881,493
R35 · FY2023 · NS · contact PI
Neuroprotection in MS: A Cell-Specific and Region-Specific Transcriptomics Approach$444,575
R01 · FY2022 · NS · contact PI
Neuroprotection in MS: A Cell-Specific and Region-Specific Transcriptomics Approach$444,575
R01 · FY2021 · NS · contact PI
Neuroprotection in MS: A Cell-Specific and Region-Specific Transcriptomics Approach$444,575
R01 · FY2020 · NS · contact PI
Parental imprinting of the X chromosome: effects on neurodegeneration$379,450
R01 · FY2020 · NS · contact PI
Neuroprotection in MS: A Cell-Specific and Region-Specific Transcriptomics Approach$444,575
R01 · FY2019 · NS · contact PI
Parental imprinting of the X chromosome: effects on neurodegeneration$379,450
R01 · FY2019 · NS · contact PI
Neuroprotection in MS: A Cell-Specific and Region-Specific Transcriptomics Approach$444,575
R01 · FY2018 · NS · contact PI
Parental imprinting of the X chromosome: effects on neurodegeneration$379,450
R01 · FY2018 · NS · contact PI
Parental imprinting of the X chromosome: effects on neurodegeneration$379,450
R01 · FY2017 · NS · contact PI
Parental imprinting of the X chromosome: effects on neurodegeneration$392,950
R01 · FY2016 · NS · contact PI
A Combination Trial of Copaxone plus Estriol in RRMS$283,739
R01 · FY2013 · NS · contact PI
A Combination Trial of Copaxone plus Estriol in RRMS$556,777
R01 · FY2012 · NS · contact PI
Treatment of Multiple Sclerosis with Sex Hormones$146,459
K24 · FY2012 · NS · contact PI
A Combination Trial of Copaxone plus Estriol in RRMS$711,730
R01 · FY2011 · NS · contact PI
Sex differences in the CNS during disease$188,650
R21 · FY2011 · NS · contact PI
Treatment of Multiple Sclerosis with Sex Hormones$148,031
K24 · FY2011 · NS · contact PI
Sex differences in the CNS during disease$231,000
R21 · FY2010 · NS · contact PI
Treatment of Multiple Sclerosis with Sex Hormones$145,292
K24 · FY2010 · NS · contact PI
A COMBINATION TRIAL OF COPAXONE PLUS ESTRIOL IN RELAPSING REMITTING MULTIPLE$6,078
P41 · FY2010 · RR · contact PI
A Combination Trial of Copaxone Plus Estriol in RRMS$860,439
R01 · FY2009 · NS · contact PI
A Combination Trial of Copaxone Plus Estriol in RRMS$500,000
R01 · FY2009 · NS · contact PI
The Effect of Sex Chromosomes on Immune Responses$359,276
R01 · FY2009 · AI · contact PI
Treatment of Multiple Sclerosis with Sex Hormones$142,633
K24 · FY2009 · NS · contact PI
A COMBINATION TRIAL OF COPAXONE PLUS ESTRIOL IN RELAPSING REMITTING MULTIPLE$6,798
P41 · FY2009 · RR · contact PI
A Combination Trial of Copaxone Plus Estriol in RRMS$500,000
R01 · FY2008 · NS · contact PI
The Effect of Sex Chromosomes on Immune Responses$359,276
R01 · FY2008 · AI · contact PI
Sex Chromosome Effects in Lupus$189,456
R21 · FY2008 · AI · contact PI
Treatment of Multiple Sclerosis with Sex Hormones$140,052
K24 · FY2008 · NS · contact PI
A COMBINATION TRIAL OF COPAXONE PLUS ESTRIOL IN RELAPSING REMITTING MULTIPLE$5,153
P41 · FY2008 · RR · contact PI
A Combination Trial of Copaxone Plus Estriol in RRMS$500,000
R01 · FY2007 · NS · contact PI
The Effect of Sex Chromosomes on Immune Responses$366,235
R01 · FY2007 · AI · contact PI
Sex Chromosome Effects in Lupus$193,125
R21 · FY2007 · AI · contact PI
MULTIPLE SCLEROSIS$20,078
P41 · FY2007 · RR · contact PI
The Effect of Sex Chromosomes on Immune Responses$377,173
R01 · FY2006 · AI · contact PI
The Effect of Sex Chromosomes on Immune Responses$327,841
R01 · FY2005 · AI
Protective Effect of Pregnancy Doses of Estrogens in EAE$249,365
R01 · FY2005 · NS
Protective Effect of Pregnancy Doses of Estrogens in EAE$249,365
R01 · FY2004 · NS
Role of sex chromosomes in gender differences in EAE$228,751
R01 · FY2004 · AI
Protective Effect of Pregnancy Doses of Estrogens in EAE$249,365
R01 · FY2003 · NS
Role of sex chromosomes in gender differences in EAE$228,751
R01 · FY2003 · AI
Protective Effect of Pregnancy Doses of Estrogens in EAE$249,365
R01 · FY2002 · NS
Role of sex chromosomes in gender differences in EAE$229,063
R01 · FY2002 · AI
IMMUNE MECHANISMS UNDERLYING GENDER DIFFERENCES IN EAE$172,939
R01 · FY2000 · NS